For the study, researchers examined the health data of 30,146 patients diagnosed with atrial fibrillation — an abnormal heart rhythm that causes blood flow issues, which can incite blood clots and subsequent stroke. After adjusting for age, sex, lifestyle and other risk factors, researchers found patients taking aspirin or direct oral anticoagulants like rivaroxaban and dabigatran had double the risk for acute myocardial infarction — heart attack — as patients taking vitamin k antagonists.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
“More research should be on-going as use of direct acting oral anticoagulants increases in the population,” wrote the study’s authors.
The CDC estimates 2.7 to 6.1 million people in the United States have atrial fibriallation. As the U.S. population ages, this number will likely increase.
More articles on quality:
ACA patient safety reforms reduce adverse events by 77k in New Jersey
Stem cell transplant offers first-ever cure for rare blood disorder
Mobile app use decreases in-person follow-ups after surgery
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.